Sodium hydroxide as a sclerosing agent in patients with neoplastic pleural effusion non-candidates for VATS: results of a minimally invasive protocol

2017 ◽  
Vol 70 (4) ◽  
pp. 535-544
Author(s):  
Micaela Raices ◽  
Matías E. Czerwonko ◽  
Agustin Dietrich ◽  
Alejandro Da Lozzo ◽  
Enrique Beveraggi ◽  
...  
Lung ◽  
1996 ◽  
Vol 174 (5) ◽  
Author(s):  
L.R. Teixeira ◽  
F.S. Vargas ◽  
A.O. Carmo ◽  
A. Cukier ◽  
L.M.M.F. Silva ◽  
...  

Respirology ◽  
1996 ◽  
Vol 1 (1) ◽  
pp. 69-72 ◽  
Author(s):  
C PULSIRIPUNYA ◽  
P YOUNGCHAIYUD ◽  
R PUSHPAKOM ◽  
N MARANETRA ◽  
A NANA ◽  
...  

2017 ◽  
Vol 34 (04) ◽  
pp. 337-342 ◽  
Author(s):  
Tony Ha ◽  
David Madoff ◽  
David Li

AbstractMalignant ascites and pleural effusion are significant contributors to patient symptoms such as shortness of breath, abdominal distension, and nausea in the setting of cancer. There are numerous methods employed to control such symptoms such as serial drainages, pleurodesis, and tunneled drainage catheters. Tunneled drainage catheters are a safe, effective, and a minimally invasive procedure to palliate the symptoms of malignant ascites and pleural effusion.


BMC Cancer ◽  
2019 ◽  
Vol 19 (1) ◽  
Author(s):  
Tim N. Beck ◽  
Alexander Y. Deneka ◽  
Louis Chai ◽  
Colin Kanach ◽  
Priya Johal ◽  
...  

2018 ◽  
Vol 6 (1-2) ◽  
pp. 41-44
Author(s):  
Mohammad Abdul Aziz ◽  
Shafiqur Rahman ◽  
ATM Mowladad Chowdhury ◽  
Mirza Mahbubul Hasan ◽  
Nurun Nahar Happy ◽  
...  

Background & objective: To evaluate the effectiveness and safety of 0.2% povidone iodine renal pelvic instillation as minimally invasive therapy for chyluria resistant to conservative treatment. Materials & Methods: From July 2015 to December 2016, 9 patients with chyluria were treated. There were 2 males and 7 females ranging from 30-65 years age. Cystoscopic localization of chylous efflux was done. On a day care basis under local anesthesia a 5 Fr open-ended ureteric catheter was introduced on the affected side. Freshly prepared 10 ml 0.2% Povidone iodine solution was instilled as a sclerosing agent in the renal pelvis. A total of 3 doses were given at 8-hour intervals. Unilateral instillation was done in 8 cases, and bilateral instillation was done in 1 patient. Results: Eight of 9 patients showed complete clearance. In 1 patient, recurrence was noted and a repeat injection was given after 4 weeks, with success. Conclusion: Our experience shows that povidone iodine is a safe and effective sclerosing agent in the management of chyluria. Ibrahim Card Med J 2016; 6 (1&2): 41-44


2008 ◽  
Vol 31 (4) ◽  
pp. 384-389 ◽  
Author(s):  
George Balassoulis ◽  
Lazaros Sichletidis ◽  
Dionisios Spyratos ◽  
Diamantis Chloros ◽  
Kostas Zarogoulidis ◽  
...  

2013 ◽  
Vol 62 (1) ◽  
pp. 121-126
Author(s):  
Safwat Ali M. Eldaboosy ◽  
Mousa El-shamly ◽  
Khalid M. Halima ◽  
Ahmad T. Shaarawy ◽  
Ismail Alwakil ◽  
...  

2020 ◽  
Vol 20 (2) ◽  
pp. 78-81
Author(s):  
Shafiqur Rahman ◽  
Mohammad Abdul Aziz ◽  
Atm Mowladad Chowdhury ◽  
Mirza Mahbubul Hasan ◽  
Nurun Nahar Happy ◽  
...  

Objective: To evaluate the effectiveness and safety of 0.2% povidone iodine renal pelvic instillation as minimally invasive therapy for chyluria resistant to conservative treatment. Methods: From July 2015 to December 2016, 9 patients with chyluria were treated. There were 2 males and 7 females ranging from 30-65 years of age. Cystoscopic localization of chylous efflux was done. On a day care basis under local anesthesia a 5 Fr open ended ureteric catheter was introduced on the affected side. Freshly prepared 10 ml 0.2% Povidone iodine solution was instilled as a sclerosing agent in the renal pelvis. A total of 3 doses were given at 8-hour intervals. Unilateral instillation was done in 8 cases, and bilateral instillation was done in 1 patient. Result: Eight of 9 patients showed complete clearance. In 1 patient, recurrence was noted and a repeat injection was given after 4 weeks, with success. Conclusion: Our experience shows that povidone iodine is a safe and effective sclerosing agent in the management of chyluria Bangladesh Journal of Urology, Vol. 20, No. 2, July 2017 p.78-81


Sign in / Sign up

Export Citation Format

Share Document